Raymond James Financial Services Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,694	Closed	-$221K	–	2821
2019 Q2	$221K	Sell	2,694 -265	-9%	-$18.8K	﹤0.01%	2469
2019 Q1	$209K	Buy	+2,959	New	+$174K	﹤0.01%	2477
2018 Q3	–	Sell	-3,913	Closed	-$261K	–	2815
2018 Q2	$261K	Buy	+3,913	New	+$244K	﹤0.01%	2328
2017 Q4	–	Sell	-10,023	Closed	-$526K	–	2539
2017 Q3	$526K	Buy	10,023 +530	+6%	+$25.3K	﹤0.01%	1678
2017 Q2	$444K	Buy	9,493 +3,837	+68%	+$185K	﹤0.01%	1748
2017 Q1	$280K	Buy	+5,656	New	+$318K	﹤0.01%	1939
2016 Q4	–	Sell	-6,131	Closed	-$407K	–	2348
2016 Q3	$407K	Sell	6,131 -15	-0.2%	-$938	﹤0.01%	1607
2016 Q2	$343K	Buy	+6,146	New	+$299K	﹤0.01%	1635